What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Critics argue this structural arrangement compromised the committee's ability to function as the independent scientific check the advisory process was designed to provide
That small percentage of benzyl alcohol serves as a preservative
Lack of historical evidence to support folic acid exacerbation of the neuropathy caused by vitamin B12 deficiency
Research indicates that expired vitamins are typically safe to take, so these products are unlikely to cause side effects just because they are out of date
The peptide not only accelerates healing but also enhances the strength and resilience of tissues as they recover